197sek
4,0 %
Date:2025-10-29Time:11:01:29Latest report:Q2-2025List:NGMTicker:GTAB B
Market Cap:155 msekEnterprise Value:147 msekNet Sales:37,8 msekEarnings:-8,00 msekEmployees:0ISIN:SE0000524530

Ratios

10-year key figure history for Glycorex Transplantation turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Glycorex Transplantation with index and moving average MA50 and MA200.

Stockprice:1,97
MA50:2,02
MA200:2,24
Price/MA200:-12,1 %
RSI (14):52,5
Price/MA50:-2,4 %

Description

Glycorex Transplantation is active in biotechnology. The company conducts research, development and marketing in the field of organ transplantation. The company's main product enables transplants regardless of the blood type of the donor or recipient. Transplantation using the company's product is carried out on a global level. Glycorex Transplantation was founded in 1996 and has its headquarters in Lund.

Medical Equipment